『Breast Cancer Update』のカバーアート

Breast Cancer Update

Breast Cancer Update

著者： Dr. Neil Love
無料で聴く

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.Copyright 2025 Research To Practice. All Rights Reserved 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

    ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists
    2026/09/03

    Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:

    • Introduction (0:00)
    • HER2 History (1:32)
    • Cases from the GMO Survey (7:06)
    • Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
    • Faculty Case Presentations (31:37)
    • Patterns of Care Survey — Part 1 (38:26)
    • Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53)
    • Faculty Case Presentations (54:13)

    CME information and select publications
    続きを読む 一部表示
    58 分
  • Metastatic Triple-Negative Breast Cancer — Patterns of Care

    Metastatic Triple-Negative Breast Cancer — Patterns of Care
    2026/08/28

    Featuring perspectives from Prof Peter Schmid and Dr Melinda Telli, including the following topics:

    • Introduction: TROP2-Targeting Antibody-Drug Conjugates (ADCs) for Metastatic Triple-Negative Breast Cancer (0:00)
    • First-Line Therapy (PD-L1 Negative) (6:53)
    • First-Line Therapy (PD-L1 Positive) (23:40)
    • Second-Line Therapy (Sequencing) (34:08)
    • Adverse Events with TROP2-Targeting ADCs (43:43)

    CME information and select publications
    続きを読む 一部表示
    1 時間 2 分
  • HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

    HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway
    2026/08/24

    Featuring perspectives from Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics:

    • Introduction: San Antonio Memories (0:00)
    • PI3K/AKT/PTEN Alterations and Therapies (7:18)
    • Capivasertib (20:22)
    • Gedatolisib (34:08)
    • Inavolisib (47:07)
    • New Agents and Ongoing Trials (52:34)

    CME information and select publications
    続きを読む 一部表示
    59 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません